Longriver Investment Partners
Overview
An independent investment manager based in Hong Kong that runs a global equity strategy with a focus on value investing principles.
Portfolio Companies
7
Website
longriverinv.comInvestments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Ouro Medicines | Jan 2025 | Series A | Co-investor |
| Rona Therapeutics | Jul 2024 | Series A Extension | Lead |
| Ronovo Surgical | Aug 2023 | Series B Extension | Co-investor |
| Allorion Therapeutics | Mar 2023 | Series B | Co-investor |
| Sironax | Aug 2022 | Series B | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
